0.00Open0.05Pre Close0 Volume195 Open Interest2.50Strike Price0.00Turnover0.00%IV733.33%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier-4DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6.13Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Renalytix Stock Discussion
Renalytix plc, a leading artificial intelligence-enabled in vitro diagnostics company, has announced an exciting new collaboration with the Steno Diabetes Center in Copenhagen. This partnership aims to advance precision medicine solutions for patients suffering from diabetes and chronic kidney disease ...
?????????????????????
No comment yet